How should anticoagulation be resumed after atrial septal defect (ASD) closure when warfarin was stopped five days ago?

Resuming Warfarin After ASD Closure

Resume warfarin immediately (tonight) at your usual maintenance dose, and initiate therapeutic-dose LMWH bridging starting tomorrow until your INR reaches therapeutic range (≥2.0).

Rationale and Management Algorithm

Since warfarin was stopped 5 days ago for your ASD closure procedure, you are now at the critical juncture where anticoagulation must be restarted to prevent thromboembolic complications while the device endothelializes.

Immediate Actions Required:

Tonight (Day 0):

• Restart warfarin at your previous maintenance dose 1, 2
• Do NOT use a loading dose

Tomorrow (Day 1):

• Begin therapeutic-dose LMWH (enoxaparin 1 mg/kg twice daily OR 1.5 mg/kg once daily subcutaneously) 3, 4
• This bridging is essential because warfarin takes several days to achieve therapeutic anticoagulation

Days 1-5:

• Continue both warfarin AND LMWH daily
• Check INR on Day 4 or 5

When INR ≥2.0:

• Stop LMWH
• Continue warfarin alone
• Recheck INR in one week to ensure stability 1, 2

Why Bridging is Critical for ASD Closure

Patients with ASD closure devices require anticoagulation for at least 6 months post-procedure to prevent device thrombosis during endothelialization 5, 6. The thrombotic risk is particularly elevated in the first weeks after device placement. Without bridging therapy, you would have a 5-7 day gap in anticoagulation coverage (the 5 days already elapsed plus 2-3 additional days for warfarin to become therapeutic), which poses unacceptable thrombotic risk 3.

Device-Specific Considerations:

The guidelines emphasize that ASD closure patients should receive aspirin and clopidogrel for 6 months, OR warfarin if there are additional indications such as atrial arrhythmias 5. Since you were on warfarin (not just antiplatelet therapy), this suggests you have a high-risk indication requiring full anticoagulation—making bridging even more critical.

Bleeding Risk Assessment

The timing of resumption depends on your procedure's bleeding risk:

• Low bleeding risk procedures: Resume within 24 hours 4, 7
• Moderate bleeding risk: Resume at 24-48 hours 4
• High bleeding risk procedures: Resume at 48-72 hours 4

Standard ASD closure is typically considered low-to-moderate bleeding risk, and at 5 days post-procedure, hemostasis should be well-established. The recommendation to restart tonight assumes adequate hemostasis has been achieved—if you have any ongoing bleeding concerns, consult your cardiologist immediately.

Common Pitfalls to Avoid

1. Do NOT double your warfarin dose to "catch up" for missed days 8
2. Do NOT restart warfarin without bridging if you have high thrombotic risk (which your warfarin use suggests)
3. Do NOT delay LMWH beyond 24 hours after restarting warfarin—the gap in coverage increases thrombotic risk 3
4. Do NOT stop LMWH prematurely—continue until INR is therapeutic for at least 24 hours 1, 3

Monitoring Schedule

• Day 4-5: Check INR (target ≥2.0 to discontinue LMWH)
• Day 7-10: Recheck INR to confirm stability in therapeutic range
• Ongoing: INR checks every 1-4 weeks once stable 8

Special Circumstances

If you have atrial fibrillation or flutter (common reasons for warfarin in ASD patients), your CHADS₂ score determines whether bridging is mandatory versus optional. However, given that warfarin was your baseline therapy, bridging should be performed unless your cardiologist specifically advises otherwise 4, 7.

The evidence consistently supports this approach across multiple guidelines 1, 4, 3, 4, with the 2021 BSG/ESGE guidelines providing the most recent and detailed protocols for warfarin management around procedures.